HDAC2 and B-cell chronic lymphocytic leukemia: The inhibition of HDAC1 and HDAC2 but not HDAC3, HDAC6, or HDAC8 enhanced the sensitivity of chronic lymphocytic leukemia (CLL) cells to TRAIL-induced apoptosis [98].